University Hospital, Geneva Clinical Trials
Sponsors / University Hospital, Geneva
University Hospital, Geneva is listed as the lead sponsor on 297 clinical trials registered with ClinicalTrials.gov. Across the portfolio, 28 are in recruitment, 6 are active non-recruiting, and 169 have reached completion. 27 trials have been terminated or withdrawn. The most common reasons cited for termination include slow or insufficient recruitment, investigator or site changes. Across the portfolio, planned enrollment totals 534,521 participants. Data on this page mirrors the ClinicalTrials.gov registry as of the most recent refresh.
297
Total Trials
28
Recruiting
6
Other Active
169
Completed
27
Terminated / Withdrawn
534,521
Total Enrollment
Termination reasons: Recruitment41% · Other37% · PI/or_Site11% · Safety4% · Efficacy4% · Funding4%
Recent Terminations
- Pacing-Induced Cardiomyopathy"Slow recruitment since the advent of left bundle branch area pacing"
- Coronary Artery Disease"Slow enrolment"
- Pain, Postoperative"Lack of finance"
- NCT04543708 Stopped Feb 2024Tonsillar Abscess"For efficacy reasons"
- NCT04990518 Stopped Nov 2022Low Back Pain, Mechanical"Grant not allowed"
- Mother-Infant Interaction"slow recruitment"
- Food Allergy"early termination due to insufficient recruitment"
- COVID"Low recruitement"
- Contraception"difficult recruitment"
- Open Angle Glaucoma"Principal investigator left the hospital"
Active Trials (6 total)
- NCT05713734
- NCT07173127
- NCT05071846
- NCT06335784
- NCT07404241
- Menopause NANCT06855784
- NCT07319039
- NCT07320651
- NCT07164287
- Anxiety NANCT07137377
- NCT06998251
- NCT06998264
- NCT05594706
- Bronchiolitis PHASE4NCT06108648
- NCT06163547
- NCT05066412
- NCT05641441
- NCT06740929
- NCT06618859
- Metastatic Cancer PHASE2NCT03569241